These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 23150502)

  • 21. Test characteristics of electrocardiography for detection of left ventricular hypertrophy in asymptomatic emergency department patients with hypertension.
    Mahn JJ; Dubey E; Brody A; Welch R; Zalenski R; Flack JM; Ference B; Levy PD
    Acad Emerg Med; 2014 Sep; 21(9):996-1002. PubMed ID: 25269580
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrocardiographic left ventricular hypertrophy has low diagnostic accuracy in middle-aged subjects.
    Vottonen P; Husso M; Sipola P; Vanninen R; Peuhkurinen K; Magga J
    Blood Press; 2007; 16(5):328-34. PubMed ID: 17852087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes.
    Gregg LP; Adams-Huet B; Li X; Colbert G; Jain N; de Lemos JA; Hedayati SS
    J Am Heart Assoc; 2017 Jul; 6(7):. PubMed ID: 28679558
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction - A LIFE review.
    Bang CN; Devereux RB; Okin PM
    J Electrocardiol; 2014; 47(5):630-5. PubMed ID: 25052475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECG left ventricular hypertrophy as a risk predictor of sudden cardiac death.
    Porthan K; Kenttä T; Niiranen TJ; Nieminen MS; Oikarinen L; Viitasalo M; Hernesniemi J; Jula AM; Salomaa V; Huikuri HV; Albert CM; Tikkanen JT
    Int J Cardiol; 2019 Feb; 276():125-129. PubMed ID: 30293667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study.
    Morillas P; Castillo J; Quiles J; Nuñez D; Guillén S; Maceira A; Rivera M; Bertomeu V
    Rev Esp Cardiol; 2008 Sep; 61(9):972-5. PubMed ID: 18775240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Jain A; Tandri H; Dalal D; Chahal H; Soliman EZ; Prineas RJ; Folsom AR; Lima JA; Bluemke DA
    Am Heart J; 2010 Apr; 159(4):652-8. PubMed ID: 20362725
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Accuracy of ECG criteria for the diagnosis of left ventricular hypertrophy: a comparison with magnetic resonance imaging.
    Krittayaphong R; Nomsawadi V; Muenkaew M; Miniphan M; Yindeengam A; Udompunturak S
    J Med Assoc Thai; 2013 Feb; 96 Suppl 2():S124-32. PubMed ID: 23590032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical value of regression of electrocardiographic left ventricular hypertrophy after aortic valve replacement.
    Yamabe S; Dohi Y; Higashi A; Kinoshita H; Sada Y; Hidaka T; Kurisu S; Shiode N; Kihara Y;
    Heart Vessels; 2016 Sep; 31(9):1497-503. PubMed ID: 26531830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.
    Engle SK; Solter PF; Credille KM; Bull CM; Adams S; Berna MJ; Schultze AE; Rothstein EC; Cockman MD; Pritt ML; Liu H; Lu Y; Chiang AY; Watson DE
    Toxicol Sci; 2010 Apr; 114(2):183-92. PubMed ID: 20044590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serial evaluation of electrocardiographic left ventricular hypertrophy for prediction of risk in hypertensive patients.
    Okin PM
    J Electrocardiol; 2009; 42(6):584-8. PubMed ID: 19631946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.
    Nomsawadi V; Krittayaphong R
    Ann Noninvasive Electrocardiol; 2019 Jul; 24(4):e12635. PubMed ID: 30719815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Electrocardiogram Is a Poor Diagnostic Tool to Detect Left Ventricular Hypertrophy in Children: A Comparison with Echocardiographic Assessment of Left Ventricular Mass.
    Bratincsák A; Williams M; Kimata C; Perry JC
    Congenit Heart Dis; 2015; 10(4):E164-71. PubMed ID: 25600360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Racial Differences in Malignant Left Ventricular Hypertrophy and Incidence of Heart Failure: A Multicohort Study.
    Lewis AA; Ayers CR; Selvin E; Neeland I; Ballantyne CM; Nambi V; Pandey A; Powell-Wiley TM; Drazner MH; Carnethon MR; Berry JD; Seliger SL; DeFilippi CR; de Lemos JA
    Circulation; 2020 Mar; 141(12):957-967. PubMed ID: 31931608
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events.
    Okin PM; Devereux RB; Jern S; Kjeldsen SE; Julius S; Nieminen MS; Snapinn S; Harris KE; Aurup P; Edelman JM; Wedel H; Lindholm LH; Dahlöf B;
    JAMA; 2004 Nov; 292(19):2343-9. PubMed ID: 15547161
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Echocardiographic assessment and N-terminal pro-brain natriuretic peptide in hypertensives with metabolic syndrome.
    Krzesiński P; Uziebło-Życzkowska B; Gielerak G; Stańczyk A; Piotrowicz K; Piechota W; Smurzyński P; Skrobowski A
    Adv Clin Exp Med; 2017; 26(2):295-301. PubMed ID: 28791849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients : the losartan intervention for endpoint (LIFE) reduction in hypertension study.
    Okin PM; Jern S; Devereux RB; Kjeldsen SE; Dahlöf B;
    Hypertension; 2000 Jan; 35(1 Pt 1):13-8. PubMed ID: 10642268
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complementary prognostic value of cystatin C, N-terminal pro-B-type natriuretic Peptide and cardiac troponin T in patients with acute heart failure.
    Manzano-Fernández S; Boronat-Garcia M; Albaladejo-Otón MD; Pastor P; Garrido IP; Pastor-Pérez FJ; Martínez-Hernández P; Valdés M; Pascual-Figal DA
    Am J Cardiol; 2009 Jun; 103(12):1753-9. PubMed ID: 19539088
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.